Horizon Investments’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Horizon Investments's ELV Position: Q2 2026 in Review
Horizon Investments increased its Elevance Health (ELV) stake by 1% in Q2 2026, buying an estimated $23.4K and bringing the position to 6,171 shares worth $2.39M. The position accounts for 0.03% of the portfolio, ranked #477.
Horizon Investments first reported a position in ELV in Q1 2019 and has held it in 19 quarters since. The position peaked at $5.84M in Q4 2025. 1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Horizon Investments held 6,171 shares of Elevance Health worth $2.39M as of Q2 2026.
- Horizon Investments bought 63 Elevance Health shares in Q2 2026, an estimated $23.4K.
- Elevance Health made up 0.03% of Horizon Investments's portfolio in Q2 2026, its #477 holding.
- Horizon Investments first reported a position in Elevance Health in Q1 2019 and has held it in 19 quarters since.
- Horizon Investments's Elevance Health position peaked at $5.84M in Q4 2025.
- 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Horizon Investments's 13F filing for Q2 2026, filed 13 Aug 2026.